Explore Metabolic & Weight Research Peptides from BioMatrix Compounds, a research-focused collection for laboratory studies involving metabolic regulation, GLP-1 receptor biology, glucose homeostasis, endocrine signaling, energy balance and related molecular pathways.

This category includes research compounds relevant to the growing field of metabolic and peptide pharmacology research. Products such as semaglutide and retatrutide can be investigated within research programs examining receptor signaling, glucose metabolism, endocrine pathways and energy-balance mechanisms. Each product has its own defined composition, specifications and research context, so researchers should review the individual product page for current information.

Metabolic Research

Metabolism involves interconnected biological pathways that regulate energy production, nutrient utilization, glucose handling, hormonal signaling and cellular responses. Research into these mechanisms can involve receptors, peptides, hormones, intracellular signaling pathways and interactions between metabolic tissues.

Metabolic & Weight Research Peptides provide researchers with compounds relevant to laboratory investigations of these mechanisms. Depending on the specific compound, research may involve GLP-1 receptor signaling, GIP receptor pathways, glucagon receptor biology, insulin signaling, glucose homeostasis, energy-balance pathways and peptide pharmacology.

The scientific evidence differs between compounds and research models. Some compounds have been evaluated in human clinical studies, while others remain primarily investigational or preclinical. Research findings should therefore be interpreted according to the specific experimental model, study design and available evidence.

GLP-1 Receptor Research

GLP-1 receptor biology is an important area within metabolic research. GLP-1 is an endogenous peptide hormone, and the GLP-1 receptor is involved in signaling pathways relevant to glucose regulation, endocrine function and energy balance.

Semaglutide is a long-acting GLP-1 receptor agonist that has been extensively investigated in metabolic research. Laboratory and clinical research has examined its receptor pharmacology and downstream metabolic effects.

Retatrutide represents a different research approach. It is a single peptide designed to activate the GLP-1, GIP and glucagon receptors, making it relevant to research into multi-receptor metabolic signaling. A 2026 phase 3 clinical study described retatrutide as a GIP, GLP-1 and glucagon receptor agonist and evaluated its effects in adults with type 2 diabetes. (PubMed)

The existence of clinical research does not mean that a research-grade product sold for laboratory purposes is an approved treatment or that findings from clinical studies automatically apply to an individual research product.

Research Areas

Compounds within this category may be relevant to laboratory investigations involving:

  • GLP-1 receptor biology
  • GIP receptor signaling
  • Glucagon receptor research
  • Glucose homeostasis
  • Metabolic regulation
  • Endocrine signaling
  • Insulin-related signaling pathways
  • Energy-balance mechanisms
  • Peptide pharmacology
  • Cellular metabolism
  • Molecular and biochemical research
  • Comparative receptor studies

Researchers can select individual compounds according to the biological pathway and experimental question being investigated.

Semaglutide Research

Semaglutide is an important compound within the GLP-1 research field. Research involving semaglutide includes investigations into GLP-1 receptor activation, receptor signaling, glucose metabolism and broader metabolic pathways.

BioMatrix Compounds offers Semaglutide 20mg as a research-grade compound with stated ≥99% purity, supplied as a white to off-white lyophilized powder in a sterile multidose vial.

Researchers should consult the individual product page for the current product specifications and available documentation rather than assuming that all semaglutide products have identical composition, quality or regulatory status.

Retatrutide Research

Retatrutide is another significant compound within metabolic research. Unlike selective GLP-1 receptor agonists, retatrutide is characterized by activity at three receptor systems: GLP-1, GIP and glucagon.

This multi-receptor profile makes retatrutide relevant to research into the interaction between different endocrine and metabolic signaling pathways. Published studies have investigated retatrutide in metabolic disease and weight-related research, including randomized clinical trials. (PubMed)

For laboratory research, the scientific literature should be considered alongside the exact specifications and intended research application of the compound being studied.

Research-Grade Quality

BioMatrix Compounds focuses on clearly specified research compounds intended for laboratory applications. Product pages may provide information regarding compound identity, strength, stated purity, physical format, storage requirements and other available specifications.

Where available, Certificates of Analysis (COAs) can provide additional analytical information for evaluating product specifications and consistency. Researchers should review the documentation associated with each individual product before beginning laboratory work.

Research compounds should not be assumed to have the same regulatory status, manufacturing standards or evidence base as Health Canada-authorized prescription medicines.

Canadian Regulatory Context

Researchers purchasing compounds in Canada should understand the distinction between a product marketed for laboratory research and an authorized prescription medicine.

Health Canada has warned Canadians about unauthorized and counterfeit GLP-1 products, including semaglutide, noting that unauthorized products may not have been assessed for safety, effectiveness or quality. Health Canada has also stated that injectable peptide drugs are regulated as prescription drugs in Canada and has taken enforcement action concerning unauthorized injectable peptides. (Health Canada)

Accordingly, research-use labeling should not be interpreted as an exemption from applicable Canadian laws or regulations. Researchers and purchasers are responsible for ensuring that their procurement, handling, storage, testing and other activities comply with applicable federal, provincial and local requirements.

Research Use Only

All products in the Metabolic & Weight Research Peptides category are supplied strictly for laboratory research purposes.

These products are not intended for human consumption, self-administration, veterinary use, diagnosis, treatment, prevention or cure of any disease or medical condition. Nothing on this category page should be interpreted as medical advice or as a recommendation for weight management or treatment.

The purpose of this collection is to provide researchers with access to compounds relevant to metabolic, endocrine and peptide-pharmacology research. Scientific evidence should be evaluated independently for each compound, including its mechanism, experimental model, study quality and limitations.

Explore BioMatrix Compounds Metabolic & Weight Research Peptides for laboratory research involving GLP-1 receptor biology, metabolic regulation, glucose signaling, endocrine pathways and energy-balance research.

Clear filters
No products were found matching your selection.